Brain Glutamate Levels Are Decreased in Alzheimer’s Disease: A Magnetic Resonance Spectroscopy Study

Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915 · see citing works

<i>The Brain's Default Network</i>: <i>Anatomy, Function, and Relevance to Disease</i>

Buckner, R. L., Andrews‐Hanna, J. R., & Schacter, D. L. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1440.011 · Cited by 9,761 · see citing works

Mild Cognitive Impairment: Clinical Characterization and Outcome

Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999) · Archives of Neurology · doi:10.1001/archneur.56.3.303 · Cited by 8,980 · see citing works

Estimation of metabolite concentrations from localized in vivo proton NMR spectra

Provencher, S. W. (1993) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910300604 · Cited by 3,659 · see citing works

Excitotoxic cell death

Choi, D. W. (1992) · Journal of Neurobiology · doi:10.1002/neu.480230915 · Cited by 2,304 · see citing works

Memantine in Moderate-to-Severe Alzheimer's Disease

Reisberg, B., Doody, R., Stöffler, A., Schmitt, F., Ferris, S., & Möbius, H. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa013128 · Cited by 2,043 · see citing works

Memantine for dementia

McShane, R., Areosa Sastre, A., & Minakaran, N. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003154.pub5 · Cited by 1,155 · see citing works

Amyloid Deposition Is Associated with Impaired Default Network Function in Older Persons without Dementia

Sperling, R. A., LaViolette, P. S., O'Keefe, K., O'Brien, J., Rentz, D. M., Pihlajamaki, M., Marshall, G., Hyman, B. T., Selkoe, D. J., Hedden, T., et al. (2009) · Neuron · doi:10.1016/j.neuron.2009.07.003 · Cited by 1,027 · see citing works

Pharmacology of glutamate neurotoxicity in cortical cell culture: attenuation by NMDA antagonists

Choi, D. W., Koh, J., & Peters, S. (1988) · Journal of Neuroscience · doi:10.1523/jneurosci.08-01-00185.1988 · Cited by 983 · see citing works

Memantine is a clinically well tolerated N-methyl-d-aspartate (NMDA) receptor antagonist—a review of preclinical data

Parsons, C. G., Danysz, W., & Quack, G. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00019-2 · Cited by 881 · see citing works

Screening for dementia with the Memory Impairment Screen

Herman Buschke, L., Kuslansky, G., Katz, M., Stewart, W. F., Sliwinski, M. J., Eckholdt, H., & Lipton, R. B. (1999) · Neurology · doi:10.1212/wnl.52.2.231 · Cited by 650 · see citing works

Functional Alterations in Memory Networks in Early Alzheimer’s Disease

Sperling, R. A., Dickerson, B. C., Pihlajamaki, M. M., Vannini, P., LaViolette, P. S., Vitolo, O. V., Hedden, T., Becker, J. A., Rentz, D. M., Selkoe, D. J., et al. (2010) · NeuroMolecular Medicine · doi:10.1007/s12017-009-8109-7 · Cited by 587 · see citing works

Fibroblast growth factor and glutamate: opposing roles in the generation and degeneration of hippocampal neuroarchitecture

Mattson, M., Murrain, M., Guthrie, P., & Kater, S. (1989) · The Journal of Neuroscience · doi:10.1523/jneurosci.09-11-03728.1989 · Cited by 409 · see citing works

Failures and successes of NMDA receptor antagonists: Molecular basis for the use of open-channel blockers like memantine in the treatment of acute and chronic neurologic insults

Lipton, S. A. (2004) · NeuroRx · doi:10.1602/neurorx.1.1.101 · Cited by 401 · see citing works

Long-term synaptic plasticity in hippocampal interneurons

Kullmann, D. M., & Lamsa, K. P. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2207 · Cited by 340 · see citing works

Memantine Treatment in Mild to Moderate Alzheimer Disease: A 24-Week Randomized, Controlled Trial

Peskind, E. R., Potkin, S. G., Pomara, N., Ott, B. R., Graham, S. M., Olin, J. T., & McDonald, S. (2006) · American Journal of Geriatric Psychiatry · doi:10.1097/01.jgp.0000224350.82719.83 · Cited by 306 · see citing works

Effects of Ketamine on Anterior Cingulate Glutamate Metabolism in Healthy Humans: A 4-T Proton MRS Study

Rowland, L. M., Bustillo, J. R., Mullins, P. G., Jung, R. E., Lenroot, R., Landgraf, E., Barrow, R., Yeo, R., Lauriello, J., & Brooks, W. M. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.2.394 · Cited by 304 · see citing works

Magnetic Resonance Spectroscopy Diagnosis of Neurological Diseases

Danielsen, E. R. (1999) · CRC Press eBooks · doi:10.1201/9781482270105 · Cited by 303 · see citing works

Magnetic resonance spectroscopy in AD

Valenzuela, M., & Sachdev, P. S. (2001) · Neurology · doi:10.1212/wnl.56.5.592 · Cited by 256 · see citing works

Cerebral blood flow and metabolic abnormalities in Alzheimer’s disease

Matsuda, H. (2001) · Annals of Nuclear Medicine · doi:10.1007/bf02988596 · Cited by 233 · see citing works

Longitudinal 1H MRS changes in mild cognitive impairment and Alzheimer's disease

Kantarci, K., Weigand, S. D., Petersen, R. C., Boeve, B. F., Knopman, D. S., Gunter, J. L., Reyes, D. A., Shiung, M. S., O’Brien, P. C., Smith, G. E., et al. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.06.018 · Cited by 213 · see citing works

[Cognocitive mini-test (a simple practical test to detect intellectual changes in medical patients)].

Lobo, A., Ezquerra, J., Gómez Burgada, F., Sala, J. M., & Seva Díaz, A. (1979) · PubMed · Cited by 194 · see citing works

β-Amyloid Causes Depletion of Synaptic Vesicles Leading to Neurotransmission Failure

Parodí, J., Sepúlveda, F. J., Roa, J., Opazo, C., Inestrosa, N. C., & Aguayo, L. G. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.030023 · Cited by 179 · see citing works

Reduced hippocampal glutamate in Alzheimer disease

Rupsingh, R., Borrie, M., Smith, M., Wells, J. L., & Bartha, R. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.05.002 · Cited by 177 · see citing works

Neuronal death in vitro: parallelism between survivability of hippocampal neurones and sustained elevation of cytosolic Ca2+ after exposure to glutamate receptor agonist

Ogura, A., Miyamoto, M., & Kudo, Y. (1988) · Experimental Brain Research · doi:10.1007/bf00406601 · Cited by 176 · see citing works

Alzheimer Disease: Postmortem Neuropathologic Correlates of Antemortem1H MR Spectroscopy Metabolite Measurements1

Kantarci, K., Knopman, D. S., Dickson, D. W., Parisi, J. E., Whitwell, J. L., Weigand, S. D., Josephs, K. A., Boeve, B. F., Petersen, R. C., & Jack, C. R. (2008) · Radiology · doi:10.1148/radiol.2481071590 · Cited by 163 · see citing works

Comparative Diagnostic Utility of Different MR Modalities in Mild Cognitive Impairment and Alzheimer’s Disease

Kantarci, K., Xu, Y., Shiung, M. M., O’Brien, P. C., Cha, R. H., Smith, G. E., Ivnik, R. J., Boeve, B. F., Edland, S. D., Kokmen, E., et al. (2002) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000066021 · Cited by 158 · see citing works

A metabolomic study of the CRND8 transgenic mouse model of Alzheimer's disease

Salek, R. M., Xia, J., Innes, A. E., Sweatman, B. C., Adalbert, R., Randle, S. J., McGowan, E. M., Emson, P. C., & Griffin, J. L. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.04.001 · Cited by 146 · see citing works

Memantine Treatment in Patients with Mild to Moderate Alzheimer's Disease: Results of a Randomised, Double-Blind, Placebo-Controlled 6-Month Study

Bakchine, S., & Loft, H. (2007) · Journal of Alzheimer s Disease · doi:10.3233/jad-2007-11409 · Cited by 136 · see citing works

Conversion From Mild Cognitive Impairment to Probable Alzheimer’s Disease Predicted by Brain Magnetic Resonance Spectroscopy

Modrego, P. J., Fayed, N., & Pina, M. A. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.4.667 · Cited by 135 · see citing works

Glutamate and the glutamate receptor system: a target for drug action

Bleich, S., R�mer, K., Wiltfang, J., & Kornhuber, J. (2003) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.933 · Cited by 125 · see citing works

Decreased glutamate + glutamine in Alzheimer’s disease detected in vivo with ¹ H-MRS at 0.5 T

Antuono, P. G., Jones, J. L., Wang, Y., & Li, S.-J. (2001) · Neurology · doi:10.1212/wnl.56.6.737 · Cited by 119 · see citing works

In vivo quantitative proton MRSI study of brain development from childhood to adolescence

Horská, A., Kaufmann, W. E., Brant, L. J., Naidu, S., Harris, J. C., & Barker, P. B. (2002) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.10057 · Cited by 117 · see citing works

Proton MR spectroscopic study at 3 Tesla on glutamate/glutamine in Alzheimer’s disease

Hattori, N., Abe, K., Sakoda, S., & Sawada, T. (2002) · Neuroreport · doi:10.1097/00001756-200201210-00041 · Cited by 112 · see citing works

Memantine for dementia

Areosa, S. A., Sherriff, F., & McShane, R. H. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003154.pub3 · Cited by 99 · see citing works

Amyloid-β Decreases Cell-Surface AMPA Receptors by Increasing Intracellular Calcium and Phosphorylation of GluR2

Liu, S.-J., Gasperini, R., Foa, L., & Small, D. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-091654 · Cited by 84 · see citing works

Low Striatal Glutamate Levels Underlie Cognitive Decline in the Elderly: Evidence from In Vivo Molecular Spectroscopy

Zahr, N. M., Mayer, D., Pfefferbaum, A., & Sullivan, E. V. (2008) · Cerebral Cortex · doi:10.1093/cercor/bhm250 · Cited by 79 · see citing works

Memantine versus donepezil in mild to moderate Alzheimer’s disease: a randomized trial with magnetic resonance spectroscopy

Modrego, P. J., Fayed, N., Errea, J. M., Ríos, C., Pina, M. A., & Sarasa, M. (2009) · European Journal of Neurology · doi:10.1111/j.1468-1331.2009.02816.x · Cited by 64 · see citing works

Utility of Different MR Modalities in Mild Cognitive Impairment and Its Use as a Predictor of Conversion to Probable Dementia

Fayed, N. M., Dávila, J., Oliveros, A., Castillo, J., & Medrano, J. (2008) · Academic Radiology · doi:10.1016/j.acra.2008.04.008 · Cited by 63 · see citing works

Magnetic resonance spectroscopy in the prediction of early conversion from amnestic mild cognitive impairment to dementia: a prospective cohort study

Modrego, P. J., Fayed, N. M., & Sarasa, M. (2011) · BMJ Open · doi:10.1136/bmjopen-2010-000007 · Cited by 56 · see citing works

A Review of 1H MR Spectroscopy Findings in Alzheimer's Disease

Soher, B. J., Doraiswamy, P. M., & Charles, H. C. (2005) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2005.09.013 · Cited by 35 · see citing works

Comparative test–retest reliability of metabolite values assessed with magnetic resonance spectroscopy of the brain. The LCModel versus the manufacturer software

Fayed, N. M., Modrego, P. J., & Medrano, J. (2009) · Neurological Research · doi:10.1179/174313209x395481 · Cited by 33 · see citing works

Correlation of findings in advanced MR techniques with global severity scales in patients with some grade of cognitive impairment

Fayed, N. M., Dávila, J., Oliveros, A., Medrano, J., & Castillo, J. (2010) · Neurological Research · doi:10.1179/174313209x405164 · Cited by 18 · see citing works

Glutamato y enfermedad de Alzheimer

Abío, J. G., & Cavero-Nagore, M. (2006) · Revista de Neurología · doi:10.33588/rn.4207.2005223 · Cited by 17 · see citing works

Glutamate metabolism and recycling at the excitatory synapse in health and neurodegeneration

Andersen, J. V., Markussen, K. H., Jakobsen, E., Schousboe, A., Waagepetersen, H. S., Rosenberg, P. A., & Aldana, B. I. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108719 · Cited by 375 · see citing works

Association of Altered Liver Enzymes With Alzheimer Disease Diagnosis, Cognition, Neuroimaging Measures, and Cerebrospinal Fluid Biomarkers

Nho, K., Kueider-Paisley, A., Ahmad, S., MahmoudianDehkordi, S., Arnold, M., Risacher, S. L., Louie, G., Blach, C., Baillie, R., Han, X., et al. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.7978 · Cited by 227 · see citing works

Mitochondrial Dysfunction and Synaptic Transmission Failure in Alzheimer’s Disease

Guo, L., Tian, J., & Du, H. (2017) · Journal of Alzheimer’s Disease · doi:10.3233/jad-160702 · Cited by 211 · see citing works

Alzheimer’s disease: Targeting the glutamatergic system

Conway, M. E. (2020) · Biogerontology · doi:10.1007/s10522-020-09860-4 · Cited by 180 · see citing works

Almond, hazelnut and walnut, three nuts for neuroprotection in Alzheimer’s disease: A neuropharmacological review of their bioactive constituents

Gorji, N., Moeini, R., & Memariani, Z. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.12.003 · Cited by 154 · see citing works

Alzheimer’s disease: amino acid levels and brain metabolic status

Gueli, M. C., & Taibi, G. (2013) · Neurological Sciences · doi:10.1007/s10072-013-1289-9 · Cited by 140 · see citing works

Lower brain and blood nutrient status in Alzheimer's disease: Results from meta‐analyses

de Wilde, M. C., Vellas, B. J., Girault, E. M., Cetinyurek‐Yavuz, A., & Sijben, J. (2017) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1016/j.trci.2017.06.002 · Cited by 138 · see citing works

Magnetic resonance spectroscopy in mild cognitive impairment: Systematic review and meta-analysis

Tumati, S., Martens, S., & Aleman, A. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.08.004 · Cited by 132 · see citing works

Transcriptomic analysis of probable asymptomatic and symptomatic alzheimer brains

Patel, H., Hodges, A., Curtis, C. J. C., Lee, S. H., Troakes, C., Dobson, R., & Newhouse, S. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.05.009 · Cited by 123 · see citing works

Glutamate-glutamine and GABA in brain of normal aged and patients with cognitive impairment

Huang, D., Liu, D., Yin, J., Qian, T., Shrestha, S., & Ni, H. (2016) · European Radiology · doi:10.1007/s00330-016-4669-8 · Cited by 127 · see citing works

Magnetic Resonance Spectroscopy in Alzheimer’s Disease: Systematic Review and Meta-Analysis

Wang, H., Tan, L., Wang, H.-F., Liu, Y., Yin, R.-H., Wang, W.-Y., Chang, X.-L., Jiang, T., & Yu, J.-T. (2015) · Journal of Alzheimer’s Disease · doi:10.3233/jad-143225 · Cited by 123 · see citing works

Metabolic Alterations Associated to Brain Dysfunction in Diabetes

Duarte, J. M. N. (2014) · Aging and Disease · doi:10.14336/ad.2014.1104 · Cited by 104 · see citing works

Implications of microbe-derived ɣ-aminobutyric acid (GABA) in gut and brain barrier integrity and GABAergic signaling in Alzheimer’s disease

Conn, K. A., Borsom, E. M., & Cope, E. K. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2371950 · Cited by 105 · see citing works

Slow Excitotoxicity in Alzheimer's Disease

Ong, W.-Y., Tanaka, K., Dawe, G. S., Ittner, L. M., & Farooqui, A. A. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-121990 · Cited by 101 · see citing works

Riluzole, a glutamate modulator, slows cerebral glucose metabolism decline in patients with Alzheimer’s disease

Matthews, D. C., Mao, X., Dowd, K., Tsakanikas, D., Jiang, C. S., Meuser, C., Andrews, R. D., Lukic, A. S., Lee, J., Hampilos, N. H., et al. (2021) · Brain · doi:10.1093/brain/awab222 · Cited by 99 · see citing works

Electrochemical detection of monosodium glutamate in foodstuffs based on Au@MoS2/chitosan modified glassy carbon electrode

Devi, R., Gogoi, S., Barua, S., Dutta, H. S., Bordoloi, M., & Khan, R. (2018) · Food Chemistry · doi:10.1016/j.foodchem.2018.10.024 · Cited by 94 · see citing works

Neurometabolites and associations with cognitive deficits in mild cognitive impairment: a magnetic resonance spectroscopy study at 7 Tesla

Oeltzschner, G., Wijtenburg, S. A., Mikkelsen, M. E., Edden, R. A. E., Barker, P. B., Joo, J. H., Leoutsakos, J., Rowland, L. M., Workman, C. I., & Smith, G. S. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.09.027 · Cited by 83 · see citing works

Posterior cingulate γ-aminobutyric acid and glutamate/glutamine are reduced in amnestic mild cognitive impairment and are unrelated to amyloid deposition and apolipoprotein E genotype

Riese, F., Gietl, A. F., Zoelch, N., Henning, A., Tuura, R., Kälin, A. M., Leh, S. E., Buck, A., Warnock, G., Edden, R. A. E., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.07.030 · Cited by 81 · see citing works

A comprehensive multiomics approach toward understanding the relationship between aging and dementia

Currais, A. J. M., Goldberg, J., Farrokhi, C. B., Chang, M. W., Prior, M., Dargusch, R., Daugherty, D., Armando, A. M., Quehenberger, O., Maher, P. A., et al. (2015) · Aging · doi:10.18632/aging.100838 · Cited by 77 · see citing works

Brain energy metabolism in glutamate-receptor activation and excitotoxicity: Role for APC/C-Cdh1 in the balance glycolysis/pentose phosphate pathway

Rodriguez‐Rodriguez, P., Almeida, Á., & Bolaños, J. P. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.02.005 · Cited by 74 · see citing works

Neuronal and Astrocytic Metabolism in a Transgenic Rat Model of Alzheimer's Disease

Nilsen, L. H., Witter, M. P., & Sonnewald, U. (2014) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2014.37 · Cited by 73 · see citing works

Glutamine metabolism in diseases associated with mitochondrial dysfunction

Bornstein, R., Mulholland, M. T., Sedensky, M. M., Morgan, P. G., & Johnson, S. C. (2023) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2023.103887 · Cited by 71 · see citing works

Moderate decline in select synaptic markers in the prefrontal cortex (BA9) of patients with Alzheimer’s disease at various cognitive stages

Poirel, O., Mella, S., Videau, C., Ramet, L., Davoli, M. A., Herzog, É., Katsel, P., Mechawar, N., Haroutunian, V. H., Epelbaum, J., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-19154-y · Cited by 69 · see citing works

Alzheimer's disease and epigenetic diet

Sezgin, Z., & Dinçer, Y. (2014) · Neurochemistry International · doi:10.1016/j.neuint.2014.09.012 · Cited by 67 · see citing works

Friend or Foe? Defining the Role of Glutamate in Aging and Alzheimer’s Disease

Cox, M. F., Hascup, E. R., Bartke, A., & Hascup, K. N. (2022) · Frontiers in Aging · doi:10.3389/fragi.2022.929474 · Cited by 70 · see citing works

The hypothalamus as the primary brain region of metabolic abnormalities in APP/PS1 transgenic mouse model of Alzheimer's disease

Zheng, H. X., Zhou, Q., Du, Y., Li, C., Xu, P., Li, L., Xiao, J., & Gao, H. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.10.028 · Cited by 69 · see citing works

A magnetic resonance spectroscopy investigation in symptomatic former NFL players

Alosco, M. L., Tripodis, Y., Rowland, B. C., Chua, A. S., Liao, H. V., Martin, B. M., Jarnagin, J., Chaisson, C. E., Pasternak, O., Karmacharya, S., et al. (2019) · Brain Imaging and Behavior · doi:10.1007/s11682-019-00060-4 · Cited by 59 · see citing works

1H NMR Metabolomic Signatures in Five Brain Regions of the AβPPswe Tg2576 Mouse Model of Alzheimer's Disease at Four Ages

Lalande-Martin, J., Halley, H., Balayssac, S., Gilard, V., Dejean, S., Martino, R., Francès, B., Lassalle, J., & Malet‐Martino, M. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-130023 · Cited by 58 · see citing works

NSCs promote hippocampal neurogenesis, metabolic changes and synaptogenesis in APP/PS1 transgenic mice

Zhang, W., Gu, G., Zhang, Q., Liu, J., Zhang, B., Guo, Y. C., Wang, M., Gong, Q., & Xu, J. (2017) · Hippocampus · doi:10.1002/hipo.22794 · Cited by 57 · see citing works

Homeostasis of the Intraparenchymal-Blood Glutamate Concentration Gradient: Maintenance, Imbalance, and Regulation

Bai, W., & Zhou, Y. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00400 · Cited by 57 · see citing works

Reduced Hippocampal Glutamate and Posterior Cingulate N-Acetyl Aspartate in Mild Cognitive Impairment and Alzheimer’s Disease Is Associated with Episodic Memory Performance and White Matter Integrity in the Cingulum: A Pilot Study

Wong, D. Y., Atiya, S., Fogarty, J., Montero‐Odasso, M., Pasternak, S., Brymer, C., BORRIE, M. J., & Bartha, R. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-190773 · Cited by 56 · see citing works

Higher Glutamate + Glutamine and Reduction of N-acetylaspartate in Posterior Cingulate According to Age Range in Patients with Cognitive Impairment and/or Pain

Fayed, N. M., Andres, E. M., Viguera, L., Modrego, P. J., & García‐Campayo, J. (2014) · Academic Radiology · doi:10.1016/j.acra.2014.04.009 · Cited by 54 · see citing works

Glial Glutamate Transporter-Mediated Plasticity: System xc-/xCT/SLC7A11 and EAAT1/2 in Brain Diseases

Dahlmanns, M., Dahlmanns, J. K., Savaskan, N. E., Steiner, H. H., & Yakubov, E. (2023) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2803057 · Cited by 52 · see citing works

Extracellular truncated tau causes early presynaptic dysfunction associated with Alzheimer’s disease and other tauopathies

Florenzano, F., Corsetti, V., Ciasca, G., Ciotti, M. T., Pittaluga, A., Olivero, G., Feligioni, M., Iannuzzi, F., Latina, V., Sciacca, M. F. M., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.17371 · Cited by 52 · see citing works

Choline and the Brain: An Epigenetic Perspective

Bekdash, R. A. (2016) · Advances in neurobiology · doi:10.1007/978-3-319-28383-8_21 · Cited by 50 · see citing works

Brain Changes in Long-Term Zen Meditators Using Proton Magnetic Resonance Spectroscopy and Diffusion Tensor Imaging: A Controlled Study

Fayed, N. M., del Hoyo, Y. L., Andres, E. M., Serrano‐Blanco, A., Bellón, J. Á., Aguilar, K., Cebolla, A., & García‐Campayo, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058476 · Cited by 48 · see citing works

Characterising Alzheimer's disease through integrative NMR- and LC-MS-based metabolomics

Nielsen, J. E., Maltesen, R. G., Havelund, J. F., Færgeman, N. J., Gotfredsen, C. H., Vestergård, K., Kristensen, S. R., & Pedersen, S. (2021) · Metabolism Open · doi:10.1016/j.metop.2021.100125 · Cited by 43 · see citing works

Reliability of 7T1H-MRS measured human prefrontal cortex glutamate, glutamine, and glutathione signals using an adapted echo time optimized PRESS sequence: A between- and within-sessions investigation

Lally, N., An, L., Banerjee, D., Niciu, M. J., Luckenbaugh, D. A., Richards, E. M., Roiser, J. P., Shen, J., Zarate, C. A., & Nugent, A. C. (2015) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.24970 · Cited by 44 · see citing works

Amyloid <i>β</i> 1-42 Induces Hypometabolism in Human Stem Cell-Derived Neuron and Astrocyte Networks

Tarczyluk, M. A., Nagel, D. A., Parri, H. R., Tse, E. H., Brown, J. E., Coleman, M. D., & Hill, E. J. (2015) · Journal of Cerebral Blood Flow &amp; Metabolism · doi:10.1038/jcbfm.2015.58 · Cited by 42 · see citing works

Altered neurochemical profile in the M cGill‐ R ‐ T hy1‐ APP rat model of A lzheimer's disease: a longitudinal in vivo 1 H MRS study

Nilsen, L. H., Melø, T. M., Sæther, O., Witter, M. P., & Sonnewald, U. (2012) · Journal of Neurochemistry · doi:10.1111/jnc.12003 · Cited by 43 · see citing works

Choline the brain and neurodegeneration insights from epigenetics

Bekdash, R. A. (2017) · Frontiers in bioscience · doi:10.2741/4636 · Cited by 41 · see citing works

An Update of the Classical and Novel Methods Used for Measuring Fast Neurotransmitters During Normal and Brain Altered Function

Castro, V., Valenzuela, C., Sanchez, J., Pena, K., López‐Pérez, S. J., Ibarra, J., & Asiares, A. V. (2014) · Current Neuropharmacology · doi:10.2174/1570159x13666141223223657 · Cited by 40 · see citing works

Decreased Glutamate Levels in Patients with Amnestic Mild Cognitive Impairment: An sLASER Proton MR Spectroscopy and PiB‐PET Study

Zeydan, B., Deelchand, D. K., Tosakulwong, N., Lesnick, T. G., Kantarci, O. H., Machulda, M. M., Knopman, D. S., Lowe, V. J., Jack, C. R., Petersen, R. C., et al. (2017) · Journal of Neuroimaging · doi:10.1111/jon.12454 · Cited by 37 · see citing works

Meta-Analysis of Neurochemical Changes Estimated via Magnetic Resonance Spectroscopy in Mild Cognitive Impairment and Alzheimer's Disease

Liu, H., Zhang, D., Lin, H., Zhang, Q., Zheng, L., Zheng, Y., Yin, X., Li, Z., Liang, S., & Huang, S. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.738971 · Cited by 36 · see citing works

Effect of C-peptide Alone or in Combination with Nicotinamide on Glucose and Insulin Levels in Streptozotocin-Nicotinamide-Induced Type 2 Diabetic Mice.

Ahangarpour, A., Akbari, F. R. A., & Moghadam, H. F. (2014) · Europe PMC (PubMed Central) · Cited by 30 · see citing works

Metabolic Features of Brain Function with Relevance to Clinical Features of Alzheimer and Parkinson Diseases

Butterfield, D. A., Favia, M., Spera, I., Campanella, A., Lanza, M., & Castegna, A. (2022) · Molecules · doi:10.3390/molecules27030951 · Cited by 28 · see citing works

A novel phenoxy thiophene sulphonamide molecule protects against glutamate evoked oxidative injury in a neuronal cell model

Gliyazova, N. S., Huh, E. Y., & Ibeanu, G. C. (2013) · BMC Neuroscience · doi:10.1186/1471-2202-14-93 · Cited by 27 · see citing works

Magnetic resonance spectroscopy analysis of neurochemical changes in the atrophic hippocampus of APP/PS1 transgenic mice

Liang, S., Huang, J., Liu, W., Jin, H., Li, L., Zhang, X., Nie, B., Lin, R., Tao, J., Zhao, S., et al. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.08.005 · Cited by 26 · see citing works

Miniaturized Electrochemical Sensing Platforms for Quantitative Monitoring of Glutamate Dynamics in the Central Nervous System

Wang, Q., Yang, C., Chen, S., & Li, J. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202406867 · Cited by 26 · see citing works

Green spectrophotometric methods for determination of a monosodium glutamate in different matrices

Ali, H. M., Hammad, S. F., & El‐Malla, S. F. (2021) · Microchemical Journal · doi:10.1016/j.microc.2021.106622 · Cited by 25 · see citing works

Increase in the extracellular glutamate level during seizures and electrical stimulation determined using a high temporal resolution technique

Medina‐Ceja, L., Pardo‐Peña, K., Morales‐Villagrán, A., Ortega‐Ibarra, J., & López‐Pérez, S. J. (2015) · BMC Neuroscience · doi:10.1186/s12868-015-0147-5 · Cited by 25 · see citing works

Longitudinal Magnetic Resonance Spectroscopy as Marker of Cognitive Deterioration in Mild Cognitive Impairment

Modrego, P., & Fayed, N. (2011) · American Journal of Alzheimers Disease & Other Dementias · doi:10.1177/1533317511433809 · Cited by 26 · see citing works

1H Magnetic Resonance Spectroscopy to Understand the Biological Basis of ALS, Diagnose Patients Earlier, and Monitor Disease Progression

Caldwell, S., & Rothman, D. L. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.701170 · Cited by 23 · see citing works

Hierarchical deconvolution for extensive cell type resolution in the human brain using DNA methylation

Zhang, Z., Wiencke, J. K., Kelsey, K. T., Koestler, D. C., Molinaro, A. M., Pike, S. C., Karra, P., Christensen, B. C., & Salas, L. A. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1198243 · Cited by 22 · see citing works

Alterations in mitochondrial number and function in Alzheimer’s disease fibroblasts

Gray, N. E., & Quinn, J. F. (2015) · Metabolic Brain Disease · doi:10.1007/s11011-015-9667-z · Cited by 21 · see citing works

Imaging Methods Applicable in the Diagnostics of Alzheimer’s Disease, Considering the Involvement of Insulin Resistance

Hnilicová, P., Kantorová, E., Šutovský, S., Grofik, M., Zeleňák, K., Kurča, E., Žilka, N., Parvanovova, P., & Kolísek, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043325 · Cited by 21 · see citing works

Hippocampal Neurochemical Changes in Senescent Mice Induced with Chronic Injection of D-Galactose and NaNO2: An In Vitro High-Resolution NMR Spectroscopy Study at 9.4T

Lin, Y., Yao, J., Chen, Y., Pang, L., Li, H., Cao, Z., You, K., Dai, H., & Wu, R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088562 · Cited by 18 · see citing works

Magnetic resonance spectroscopy and brain volumetry in mild cognitive impairment. A prospective study

Fayed, N. M., Modrego, P. J., García‐Martí, G., Sanz‐Requena, R., & Martí‐Bonmatí, L. (2016) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2016.12.010 · Cited by 18 · see citing works

The relationship between measurement of in vivo brain glutamate and markers of iron metabolism: A proton magnetic resonance spectroscopy study in healthy adults

Burger, A., Kotze, M. J., Stein, D. J., van Rensburg, S. J., & Howells, F. M. (2019) · European Journal of Neuroscience · doi:10.1111/ejn.14583 · Cited by 17 · see citing works

Cyanidin-3- O-glucoside alleviates trimethyltin chloride-induced neurodegeneration by maintaining glutamate homeostasis through modulation of the gut microbiota

Xi, Y., Li, W., Wang, J., Yu, M., Zeng, X., Li, H., & Li, J. (2023) · Food Science and Human Wellness · doi:10.26599/fshw.2022.9250141 · Cited by 17 · see citing works

Cardiovascular risks impact human brain N -acetylaspartate in regionally specific patterns

Chiappelli, J., Rowland, L. M., Wijtenburg, S. A., Chen, H., Maudsley, A. A., Sheriff, S., Chen, S., Savransky, A., Marshall, W., Ryan, M. C., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1907730116 · Cited by 16 · see citing works

Lower Posterior Cingulate N-Acetylaspartate to Creatine Level in Early Detection of Biologically Defined Alzheimer’s Disease

Chen, Q., Abrigo, J., Liu, W., Han, E. Y., Yeung, D. K. W., Shi, L., Au, L. W. C., Deng, M., Chen, S., Leung, E. Y. L., et al. (2022) · Brain Sciences · doi:10.3390/brainsci12060722 · Cited by 15 · see citing works

Metabolomic and Proteomic Analysis of ApoE4-Carrying H4 Neuroglioma Cells in Alzheimer’s Disease Using OrbiSIMS and LC-MS/MS

Lu, L., Kotowska, A. M., Kern, S., Fang, M., Rudd, T. R., Alexander, M. R., Scurr, D. J., & Zhu, Z. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.4c01201 · Cited by 15 · see citing works

Mechanism of Metal Complexes in Alzheimer’s Disease

Yi, L. I. U., Ma, J., Zhang, Q., Wang, Y., & Sun, Q. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252211873 · Cited by 15 · see citing works

Metabolite Profile of Alzheimer’s Disease in the Frontal Cortex as Analyzed by HRMAS 1H NMR

Zhang, Y., Liu, Z., Ji, B., Liu, L., Wu, S., Liu, X., Wang, S., & Wang, L. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00424 · Cited by 15 · see citing works

1H-MRS neurometabolites and associations with neurite microstructures and cognitive functions in amnestic mild cognitive impairment

Gozdas, E., Hinkley, L. M., Fingerhut, H., Dacorro, L., Gu, M., Sacchet, M. D., Hurd, R. E., & Hosseini, S. M. H. (2022) · NeuroImage Clinical · doi:10.1016/j.nicl.2022.103159 · Cited by 15 · see citing works

Magnetic Resonance Spectroscopy (MRS) in Alzheimer’s Disease

Sheikh‐Bahaei, N., Chen, M., & Pappas, I. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-3774-6_9 · Cited by 14 · see citing works

Cholinergic neurotransmission in the brain of streptozotocin-induced rat model of sporadic Alzheimer’s disease: long-term follow up

Knezović, A., & Šalković‐Petrišić, M. (2025) · Journal of Neural Transmission · doi:10.1007/s00702-025-02887-2 · Cited by 14 · see citing works

Frontal Metabolites and Alzheimer’s Disease Biomarkers in Healthy Older Women and Women Diagnosed with Mild Cognitive Impairment

Hone‐Blanchet, A., Bohsali, A. A., Krishnamurthy, L. C., Shahid, S. S., Lin, Q., Zhao, L., Bisht, A. S., John, S. E., Loring, D. W., Goldstein, F. C., et al. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215431 · Cited by 14 · see citing works

Hydrogen Proton Magnetic Resonance Spectroscopy in Multidomain Amnestic Mild Cognitive Impairment and Vascular Cognitive Impairment Without Dementia

Chen, S., Cai, Q., Shen, Y., Chuanxiao, X., Zhou, H., & Zhao, Z. (2016) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317515628052 · Cited by 15 · see citing works

Scutellarin ameliorates the stress‐induced anxiety‐like behaviors in mice by regulating neurotransmitters

Guo, Y., Zhou, Y., Li, Y., Liu, A., Yue, J., Liu, Q., Yang, L., Wu, Y., Liu, S., Zhang, K., et al. (2021) · Phytotherapy Research · doi:10.1002/ptr.7106 · Cited by 12 · see citing works

Systemic Metabolism and Mitochondria in the Mechanism of Alzheimer’s Disease: Finding Potential Therapeutic Targets

Song, M., & Fan, X. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098398 · Cited by 11 · see citing works

Two-dimensional gel electrophoresis revealed antipsychotic drugs induced protein expression modulations in C6 glioma cells

Chen, M. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.08.013 · Cited by 12 · see citing works

Oral Galactose Provides a Different Approach to Incretin-Based Therapy of Alzheimer's Disease

Šalković‐Petrišić, M. (2018) · Journal of Neurology and Neuromedicine · doi:10.29245/2572.942x/2018/4.1204 · Cited by 12 · see citing works

A Highly Sensitive Immunosensor Based on In Situ Reduced Gold-Chitosan Nanocomposite for Detection of Monosodium L-glutamate

Sharma, D., Devi, R., Jaiswal, J., Dutta, H. S., Khan, R., & Dhayal, M. (2022) · Journal of Biosystems Engineering · doi:10.1007/s42853-022-00127-z · Cited by 11 · see citing works

Metabolite changes in the posterior cingulate cortex could be a signature for early detection of Alzheimer’s disease: a systematic review and meta-analysis study based on 1H-NMR

Rahim, F., Khalafi, M., Davoodi, M., & Shirbandi, K. (2023) · The Egyptian Journal of Neurology Psychiatry and Neurosurgery · doi:10.1186/s41983-023-00649-z · Cited by 10 · see citing works

Magnetic Resonance Spectroscopy Study of Amnestic Mild Cognitive Impairment and Vascular Cognitive Impairment With No Dementia

Liu, Y., Yang, Z., Shen, Z., Xiao, Y., Cheng, X., Chen, W., Chen, Y., & Wu, R. (2013) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317513495106 · Cited by 10 · see citing works

Factor H’s Control of Complement Activation Emerges as a Significant and Promising Therapeutic Target for Alzheimer’s Disease Treatment

Hasantari, I., Nicolas, N., Alzieu, P., Leval, L., Shalabi, A., Grolleau, S., & Dinet, V. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042272 · Cited by 9 · see citing works

Magnetic Resonance Spectroscopy

Merugumala, S. K., Ramadan, S., Keenan, W., Liao, H. V., Wang, L. Y.-J., & Lin, A. (2014) · Springer eBooks · doi:10.1007/978-3-642-54542-9_6 · Cited by 9 · see citing works

The Interface between Depression and Alzheimer’s Disease. A Comprehensive Approach

Modrego, P. J., de Cerio, L. D., & Lobo, A. (2023) · Annals of Indian Academy of Neurology · doi:10.4103/aian.aian_326_23 · Cited by 8 · see citing works

Multimodal investigation of neuropathology and neurometabolites in mild cognitive impairment and late-life depression with 11C-PiB beta-amyloid PET and 7T magnetic resonance spectroscopy

Davies‐Jenkins, C. W., Workman, C. I., Hupfeld, K. E., Zöllner, H. J., Leoutsakos, J., Kraut, M. A., Barker, P. B., Smith, G. S., & Oeltzschner, G. (2024) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2024.06.003 · Cited by 8 · see citing works

Centella asiatica, an Ayurvedic Medicinal Plant, Prevents the Major Neurodegenerative and Neurotoxic Mechanisms Associated with Cognitive Impairment

Ahuja, M., Patel, M., Majrashi, M., Mulabagal, V., & Dhanasekaran, M. (2017) · Medicinal and aromatic plants of the world · doi:10.1007/978-981-10-5978-0_1 · Cited by 9 · see citing works

MR spectroscopy in Alzheimer’s disease

Sheikh‐Bahaei, N. (2020) · Biomedical Spectroscopy and Imaging · doi:10.3233/bsi-200194 · Cited by 8 · see citing works

Novel cogrinding of donepezil with neurotransmitters and coumarins: characterization, physical properties and in vitro drug release study

Somphon, W., Prasertsabw, A., & Jarussophon, N. (2019) · Materials Today Proceedings · doi:10.1016/j.matpr.2019.06.227 · Cited by 7 · see citing works

Development of a mimetic system for electrochemical detection of glutamate

ALVES, L. M., de Castro, A. C. H., Oliveira, S. M., Júnior, L. C. O., Goulart, L. R., Bonetti, A. M., Machado, A. E. H., Ueira‐Vieira, C., Madurro, J. M., & Brito‐Madurro, A. G. (2016) · Journal of Solid State Electrochemistry · doi:10.1007/s10008-016-3236-1 · Cited by 6 · see citing works

Clinical Biomarkers and Novel Drug Targets to Cut Gordian Knots of Alzheimer's Disease

Mir, R. H., Masoodi, M. H., Shah, A. J., Mohi-ud-din, R., Sabreen, S., Wani, T. U., Jan, R., Javed, M. N., & Mir, P. A. (2022) · Current Molecular Pharmacology · doi:10.2174/1874467215666220903095837 · Cited by 6 · see citing works

Retrospective analysis of Braak stage– and APOE4 allele–dependent associations between MR spectroscopy and markers of tau and neurodegeneration in cognitively unimpaired elderly

Chen, A. M., Gajdošík, M., Ahmed, W., Ahn, S., Babb, J. S., Blessing, E., Boutajangout, A., de Leon, M. J., Debure, L., Gaggi, N. L., et al. (2024) · NeuroImage · doi:10.1016/j.neuroimage.2024.120742 · Cited by 5 · see citing works

Highly sensitive electrochemical detection of monosodium glutamate and nitrite on a binary metal (FeZnO) nanocomposite

Mayildurai, R., Mahalakshmi, S., Maruthavanan, T., Vijayakumari, K. K., Priya, R., Ramesh, M., & Chinnusamy, S. (2025) · New Journal of Chemistry · doi:10.1039/d5nj00212e · Cited by 5 · see citing works

Modeling of Glutamate Pathway in Alzheimer's Disease using Biochemical Systems Theory

Sasidharakurup, H., M.Pradeep, M. P., Bhaskaran, M., Priya, A., Pradeep, E., Kadavath, S., Nair, B. G., & Diwakar, S. (2018) · International Conference on Advances in Computing, Communications and Informatics (ICACCI) · doi:10.1109/icacci.2018.8554550 · Cited by 5 · see citing works

DL-3-n-butylphthalide enhances synaptic plasticity in mouse model of brain impairments

Ding, Q., Yu, Q., Lei, T., Guo, Y., Zhao, J., & Yu, J. J. (2022) · STEMedicine · doi:10.37175/stemedicine.v3i1.113 · Cited by 5 · see citing works

Magnetic Resonance Spectroscopy (MRS) of the Brain

Fayed, N., & Gonzalez-Toledo, E. (2014) · Elsevier eBooks · doi:10.1016/b978-0-444-53632-7.00318-x · Cited by 5 · see citing works

Regional Mapping of Brain Glutamate Distributions Using Glutamate-Weighted Chemical Exchange Saturation Transfer Imaging

Lee, D., Woo, C., Woo, C., Kim, J. K., Kim, J. K., & Lee, D. (2020) · Diagnostics · doi:10.3390/diagnostics10080571 · Cited by 5 · see citing works

Estimating the synaptic density deficit in Alzheimer’s disease using multi-contrast CEST imaging

Shahid, S. S., Džemidžić, M., Butch, E. R., Jarvis, E., Snyder, S. E., & Wu, Y. (2024) · PLoS ONE · doi:10.1371/journal.pone.0299961 · Cited by 4 · see citing works

MXene/NiCu-MOF//AC Nanocomposite Electrode: A Dual-Functional Platform for Energy Storage and Real-Time Monitoring of Monosodium Glutamate Based Sensors

Safdar, S., Anjam, N., Muzaffar, N., Imran, M., Afzal, A. M., Iqbal, M. W., Mumtaz, S., Almutairi, T. M., Shahbaz, M. A. H., Imran, H., et al. (2024) · ECS Journal of Solid State Science and Technology · doi:10.1149/2162-8777/ad8e83 · Cited by 4 · see citing works

ABCA7 deficiency exacerbates glutamate excitotoxicity in Alzheimer’s disease mice – A new pharmacological target for Glu-related neurotoxicity

Górska, A. M., Santos‐García, I., Kvasnička, A., Dobešová, D., Friedecký, D., Gildenblat, J., & Pahnke, J. (2026) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2026.102891 · Cited by 5 · see citing works

Predicting performance in attention by measuring key metabolites in the PCC with 7T MRS

Collée, M., Rajkumar, R., Farrher, E., Hagen, J., Ramkiran, S., Schnellbächer, G. J., Khudeish, N., Shah, N. J., Veselinović, T., & Neuner, I. (2024) · Scientific Reports · doi:10.1038/s41598-024-67866-1 · Cited by 4 · see citing works

Tacrolimus mitigates pathological patterns in mouse models of Alzheimer’s disease

Gomes, G. F., Batista, C. R. Á., da Silva, M. C. M., Ferrari, C. Z., Koerich, S., Brant, M. L., Saliba, S. W., Perez, V. G., Lima, A. L. D., Ribeiro, R., et al. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118168 · Cited by 5 · see citing works

Spinal Alterations of Reil Insula in Alzheimer’s Disease

Petrides, F., Mavroudis, I. A., Spilioti, M. G., Chatzinikolaou, F. G., Costa, V., & Balogiannis, S. (2017) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317517703476 · Cited by 4 · see citing works

Sexual dimorphism, altered hippocampal glutamatergic neurotransmission, and cognitive impairment in APP knock-in mice

Findley, C. A., McFadden, S., Hill, T., Peck, M. R., Quinn, K., Hascup, K. N., & Hascup, E. R. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240795 · Cited by 3 · see citing works

Targeted UHPLC-ESI-MS/MS Analysis of Selected Neurotransmitters, Tryptophan and Its Metabolite Kynurenine in Tau Transgenic Rat Brain Tissue: A Pivotal Study

Piešťanský, J., Forgácsová, A., Olešová, D., Galba, J., Mikuš, P., Majerová, P., & Kováč, A. (2022) · Separations · doi:10.3390/separations9010016 · Cited by 3 · see citing works

Reduced hippocampal glutamate in Alzheimer disease

Rupsingh, R., Borrie, M., Smith, M., Wells, J. L., & Bartha, R. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.05.002 · Cited by 177 · see citing works

Reduced glutamate neurotransmission in patients with Alzheimer's disease?an in vivo 13C magnetic resonance spectroscopy study

Lin, A., Shic, F., Enriquez, C. M., & Ross, B. D. (2003) · Magnetic Resonance Materials in Physics Biology and Medicine · doi:10.1007/s10334-003-0004-x · Cited by 115 · see citing works

N ‐acetyl‐L‐aspartate and other amino acid metabolites in Alzheimer's disease brain

Klunk, W. E., Panchalingam, K., Moossy, J. J., McClure, R. J., & Pettegrew, J. W. (1992) · Neurology · doi:10.1212/wnl.42.8.1578 · Cited by 178 · see citing works

Magnetic resonance spectroscopic imaging enables spatial mapping of decreased glutamate levels associated with tau depositions in Alzheimer’s disease brains

Kiwamu, M., Kosei, H., Kokubo, N., Kenji, T., Hironobu, E., Keisuke, T., Hitoshi, S., Maiko, O., Chie, S., Kazunori, K., et al. (2022) · Institutional Repositories DataBase (IRDB)

Imaging of glutamate neurotransmitter alterations in Alzheimer's disease

Haris, M., Nath, K., Cai, K., Singh, A. K., Crescenzi, R. L., Kogan, F., Verma, G., Reddy, S., Hariharan, H., Melhem, E. R., et al. (2012) · NMR in Biomedicine · doi:10.1002/nbm.2875 · Cited by 147 · see citing works